Title : Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.

Pub. Date : 2019 Sep

PMID : 31326727






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The combination of liraglutide and metformin reduced the total LDL subfractions, primarily by reducing the most atherogenic subfraction LDL5, and reduced CRP but not TNF-alpha. Metformin tumor necrosis factor Homo sapiens